ClinicalTrials.Veeva

Menu

Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs

Alcon logo

Alcon

Status

Enrolling

Conditions

Presbyopia
Aphakia

Treatments

Device: Clareon PanOptix Pro/Pro Toric Trifocal IOL
Procedure: Phacoemulsification

Study type

Interventional

Funder types

Industry

Identifiers

NCT07161635
ILQ137-P001

Details and patient eligibility

About

The purpose of this study is to collect safety and performance data on two approved intraocular lenses (IOLs). This study will be conducted in participants who require cataract surgery in both eyes. The IOLs are designed to provide vision at far, arm's length, and near.

Full description

Subjects will attend 9 scheduled study visits for a total individual duration of participation of approximately 7 months. Both eyes will undergo cataract surgery. The second eye surgery will occur within 7 to 14 days of the first.

Enrollment

120 estimated patients

Sex

All

Ages

22+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Key Inclusion Criteria:

  • Subjects with cataracts in both eyes, planned for removal by routine surgery (phacoemulsification);
  • Subject must be able to understand and sign an approved informed consent form;
  • Subject is willing to complete all the required study visits for the duration of the study;
  • Other protocol-defined inclusion criteria may apply.

Key Exclusion Criteria:

  • Ocular conditions as specified in the protocol;
  • Subjects who desire monovision correction;
  • Previous intraocular or corneal surgery;
  • Other protocol-defined exclusion criteria may apply.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

120 participants in 1 patient group

Clareon PanOptix Pro/Pro Toric Trifocal IOL
Experimental group
Description:
The clouded lens will be removed by phacoemulsification, after which the PanOptix Pro and/or PanOptix Pro Toric IOLs will be implanted.
Treatment:
Procedure: Phacoemulsification
Device: Clareon PanOptix Pro/Pro Toric Trifocal IOL

Trial contacts and locations

5

Loading...

Central trial contact

Alcon Call Center

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems